Viewing StudyNCT00026338



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00026338
Status: COMPLETED
Last Update Posted: 2020-04-02
First Post: 2001-11-09

Brief Title: Gemcitabine WithOut Erlotinib in Unresectable Locally AdvancedMetastatic Pancreatic Cancer
Sponsor: NCIC Clinical Trials Group
Organization: Canadian Cancer Trials Group

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
stage III pancreatic cancer View
adenocarcinoma of the pancreas View
stage IV pancreatic cancer View